Quarterly report pursuant to Section 13 or 15(d)

Inventory

v3.22.1
Inventory
 3 Months Ended
Mar. 31, 2022
Inventory Disclosure [Abstract]  
Inventory Inventory
Inventory includes unprocessed tissue, work-in-process, Avance® Nerve Graft, Axoguard Nerve Connector®, Axoguard Nerve Protector®, Axoguard Nerve Cap®, and Axotouch® Two-Point Discriminator finished goods and supplies. Inventory is valued at the lower of cost (first-in, first-out) or net realizable value and consists of the following:
(In thousands) March 31,
2022		 December 31,
2021
Finished goods $ 11,856  $ 11,011 
Work in process 851  813 
Raw materials 4,693  4,869 
Inventory $ 17,400  $ 16,693 
The provision for inventory write-downs was $459 and $783 for the three months ended March 31, 2022, and 2021, respectively.